News for Amneal Pharmaceuticals, Inc. (AMRX)

Summary Amneal Pharmaceuticals Inc (AMRX), a global biopharmaceutical company headquartered in Bridgewater, NJ, announced its participation in two significant i

BRIDGEWATER, N.J., May 29, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. ( AMRX) will participate in two upcoming investor conferences: Jefferies Glob

Amneal Pharmaceuticals (AMRX) is set to present at two major investor conferences in June 2025. The company will attend the Jefferies Global Healthcare

**media[640880]**

Key Insights: Amneal Pharmaceuticals (AMRX) receives FDA approval for its innovative Brekiya autoinjector targeting migraines and cluster headaches. Anal

Summary Amneal Pharmaceuticals Inc (AMRX) has announced the FDA approval of Brekiya® (dihydroergotamine mesylate) injection, marking it as the first and only d

On May 12, 2025, John Kiely, a Director at Amneal Pharmaceuticals Inc (AMRX), sold 50,000 shares of the company, as reported in a SEC Filing. Following this tra

Amneal Pharmaceuticals Inc showcases a robust increase in net revenue, marking a 5.5% growth year-over-year.The company's strategic focus on Affordable Medicin

**media[618806]**

Tony DiMeo: Good morning and thank you for joining Amneal Pharmaceuticals first quarter 2025 earnings call. Today, we issued a press release reporting Q1 results.

\nRevenue: $695 million, a growth of 5% year-over-year.Adjusted EBITDA: $170 million, an increase of 12%.Adjusted EPS: $0.21, representing a 50% growth.Gross Mar

May 02, 2025 / 12:30PM GMTOperator Hello everyone and thank you for joining the Amneal Q1 2025 earnings call. Good morning and welcome to the Amneal Pharmaceuti

The following slide deck was published by Amneal Pharmaceuticals, Inc.

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Q1 2025 Earnings Call May 2, 2025 8:30 AM ETCompany ParticipantsTony DiMeo - Head, Investor RelationsChirag Patel...

We recently published a list of 10 Best Pharma Stocks to Buy for Long Term Growth. In this article, we are going to take a look at where Amneal Pharmaceuticals, Inc.

With big American pharmaceutical corporations always searching for medications in China, the US pharmaceutical industry is going through a unique trend never seen before.

Summary Amneal Pharmaceuticals Inc (AMRX), a global biopharmaceutical company, announced on [date of press release] a donation of $1.5 million to various patien

Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (”œAmneal” or the ”œCompany”), a global biopharmaceutical company, today announced donations totaling $1.5 mi

Amneal Pharmaceuticals, Inc. (AMRX), Monday announced data from a new analysis of the pivotal RISE-PD Phase 3 study, evaluating the efficacy and safety of CREXONT compared with IR CD/LD in the treatment of patients with Parkinson's disease or PD.